Titlebook: Cerebrospinal Fluid Biomarkers; Charlotte E. Teunissen,Henrik Zetterberg Book 2021 Springer Science+Business Media, LLC, part of Springer

Tyler

書目名稱Cerebrospinal Fluid Biomarkers影響因子(影響力)




書目名稱Cerebrospinal Fluid Biomarkers影響因子(影響力)學科排名




書目名稱Cerebrospinal Fluid Biomarkers網絡公開度




書目名稱Cerebrospinal Fluid Biomarkers網絡公開度學科排名




書目名稱Cerebrospinal Fluid Biomarkers被引頻次




書目名稱Cerebrospinal Fluid Biomarkers被引頻次學科排名




書目名稱Cerebrospinal Fluid Biomarkers年度引用




書目名稱Cerebrospinal Fluid Biomarkers年度引用學科排名




書目名稱Cerebrospinal Fluid Biomarkers讀者反饋




書目名稱Cerebrospinal Fluid Biomarkers讀者反饋學科排名

instulate

宿醉

Susan S. Adler,Dominiek Beckers,Math Buckby-step procedure description and address contraindications, as well as patient-related and procedure-related risk factors that can influence the development of post-LP complications. When an LP is performed correctly, the procedure is well tolerated and accepted with a low complication rate.

GEON

0893-2336 ation advice from the expertsThis volume covers the latest methods used in clinical neurochemistry laboratories for both clinical practice and research. Chapters in this book discuss topics such as techniques for cerebrospinal fluid (CSF) collection, pre-analytical processing, and basic CSF analysis

MEAN

FLAT

FLAT

Communicating Complex Results of Cerebrospinal Fluid Analysis,e interpretation of blood contaminated CSF, interpretation of the antibody specifity?index, and markers of dementia. The text output of a knowledge-based system combined with a visually oriented report form facilitates the recognition of these typical but often not apparent disease patterns.

聯(lián)邦

Method and Clinical Validation of Biomarkers for Neurodegenerative Diseases,elds with quite different implications. When talking about validation, it is therefore important to specify the subject under scrutiny and in this chapter the focus will be on validation of biomarkers.

有其法作用

Angiogenesis

Immunoassay and Mass Spectrometry Methods for Tau Protein Quantification in the Cerebrospinal Fluid represented by classical ELISA and fully automatized systems. There is however a need for a reference method represented by mass spectrometry which could help to?homogenize results across platforms and help to?decipher the diversity of the tau isoforms in CSF.